APLM
Apollomics Inc. Class A Ordinary Shares
$6.920+-0.000 (-0.000%)
即時價格
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$6.920
最高
$6.920
最低
$6.920
交易量
0.00M
公司基本面
交易統計
相關新聞
GlobeNewswire
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew interim data for
查看更多
GlobeNewswire
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。